Buttons: Top Navigation Bar
care diagnosis dual managed christian drug rehab texas addiction treatment san diego alcohol drug rehab technology
dual diagnosis definition and addiction treatment baltimore alcohol rehab newport beach
1-800-559-9503 - drug rehab los angeles
Home > GAD > Quick Facts
GENERALIZED ANXIETY DISORDER Generalized Anxiety DisorderDisorder

Generalized anxiety disorder (GAD) is much more intense than the normal anxiety people experience on a day to day basis. This anxiety is chronic and fills one's everyday life with worry and tension, even when there wasn't anything really to provoke it. An individual with this disorder constantly worries excessively about everything from income, to friends and family, or employment. GAD is perhaps better characterized by the anticipation of disaster that usually is present in every moment of the afflicted individual's day. A rudimentary event like getting through the day is enough to provoke anxiety. People experiencing this anxiety, though they know it is irrational, cannot usually shake their fears.

 
Quick Facts   People with GAD
Symptoms   Treatment  
Research        
 
Quick Facts
GAD affects about 4 million adult Americans.
About twice as many women as men are affected by the disorder.
The disorder comes on gradually and can begin across the life cycle, though the risk is highest between childhood and middle age.
GAD is diagnosed when someone spends at least 6 months worrying excessively about a number of everyday problems.
There is evidence that genes play a modest role in GAD.
GAD is commonly treated with medications.
GAD rarely occurs alone, however; it is usually accompanied by another anxiety disorder, depression, or substance abuse.
Depression
Bipolar Disorder
Anxiety Disorders
Panic Disorders
Obsessive Disorder
PTSD
Schizophrenia
Social Phobia
BPD
Specific Phobias
Gad
References

Live chat by Boldchat

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized...

AstraZeneca today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for SEROQUEL XR Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder , including maintenance of antianxiety effect.

New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder an...

AstraZeneca today announced new study data on SEROQUEL XR Extended-Release Tablets for the treatment of major depressive disorder and generalized anxiety disorder in adult patients.

HomeSpacer Anxiety Disorders Spacer  Cocaine Addiction Spacer  Addiction Treatment SpacerSpacer
©2005 Dual Diagnosis, All Rights reserved